Dis-Chem Pharmacies Limited (JSE: DCP), announced that several of its directors have recently disposed of their forfeitable share options. These transactions occurred following the vesting of the options and were conducted in compliance with the Listings Requirements of the JSE Limited.
Leading the list of directors is Ms Julia Pope, who exercised her direct beneficial interest in the company’s ordinary shares. Ms Pope had 19,974 shares vested, each with an exercise price of R23.8576. The total value of the transaction amounted to R476,531.70. These forfeitable share options were awarded to Ms Pope on 1 March 2021, and their vesting and exercise date was reached on 30 June 2023.
Joining Ms Pope is Ms Tanya Ponter, another director of Dis-Chem, who also exercised her direct beneficial interest in the company’s ordinary shares. A total of 17,037 shares were vested, with an exercise price per security of R23.8576. The transaction’s total value was R406,461.93. Similar to Ms Pope, these shares were part of the Forfeitable Share Options Plan and were awarded to Ms Ponter on 1 March 2021, with their vesting and exercise date occurring on 30 June 2023.
Additionally, Ms Nikki Lumley, the Company Secretary of Dis-Chem, participated in the share disposal. As part of the vesting of Forfeitable Share Options, Ms Lumley had 5,279 ordinary shares vested. The deemed price per security was R23.8576, resulting in a deemed total value of R125,945.85. Furthermore, Ms Lumley retained 2,825 shares through net equity settlement while trading 2,454 shares on the market, with a price per security of R23.8576 and a total transaction value of R58,546.55. The vesting of these shares took place on 30 June 2023.
It is important to note that these transactions were conducted to meet income tax obligations associated with the vesting of ordinary shares. The necessary clearances were obtained in accordance with Dis-Chem’s trading policy, demonstrating the company’s commitment to transparent and compliant operations.
This website uses cookies.
